Skip to main content Skip to main navigation menu Skip to site footer
Journal of Commercial Biotechnology
  1. Home /
  2. Archives /
  3. Vol. 20 No. 4 (2014)

Vol. 20 No. 4 (2014)

Published: 2014-10-03

Commentary

  • To Market, To Market: Ontario, Canada’s vision to improve commercialization of healthcare research

    Stephen Thompson
    • Requires Subscription PDF (USD 25)

Article

  • Genetic engineering technologies for Ethiopian agriculture: Prospects and challenges

    Adane Abraham
    • Requires Subscription PDF (USD 25)
  • Transgenic crop research and regulation in India: Whether legislation rightly drives the motion?

    Muthukrishnakumar Kandasamy, Padmavati Manchikanti
    • Requires Subscription PDF (USD 25)
  • What the patent dance of the Biosimilars Act means for biosimilars

    David A. Fazzolare, Joanna Brougher
    • Requires Subscription PDF (USD 25)

From the Boardroom

  • Biotechnology lessons for robotics: Adapting new business models to accelerate innovation

    Arthur Boni, Christopher Moehle
    • Requires Subscription PDF (USD 25)

Legal and Regulatory Updates

  • The Jordan Food and Drug Administration: A culture of quality and continuous improvement

    Hayel Mohammad Obeidat, Lina al Kayyali, Wesal al Haqaish, Nidaa Bawaraesh, Peter J. Pitts
    • Requires Subscription PDF (USD 25)
  • Trends in patent filings depict a decade of research into the genome-based technologies

    Rachel Mercer, Gareth Williams
    • Requires Subscription PDF (USD 25)

Conference Report

  • Advances in drug development & approvals landscape, and industry partnerships

    Vasu Pestonjamasp
    • Requires Subscription PDF (USD 25)

Copyright © 2021
Journal of Commercial Biotechnology
All rights reserved.
ISSN: 1462-8732 | eISSN: 1478-565X

Privacy Policy

Journal of Commercial Biotechnology

GoDaddy SiteSeal WebTrust